The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
Clinical trial NCT04465292 · UNKNOWN
Trial details
- NCT number
- NCT04465292
- Sponsor
- Brigham and Women's Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.